comparemela.com
Home
Live Updates
Prnewswire Jw Cayman Therapeutics Co - Breaking News
Pages:
Latest Breaking News On - Prnewswire jw cayman therapeutics co - Page 1 : comparemela.com
JW Therapeutics: Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress
SHANGHAI, May 30, 2024 /PRNewswire/ JW (Cayman) Therapeutics Co. Ltd (the "Company" or "JW Therapeutics", together with its subsidiaries, the "Group"), an independent and innovative biotechnology
Hong kong
Markj gilbert
A bristol myers squibb
Ltd the company
Prnewswire jw cayman therapeutics co
China national medical products administration
National significant new drug development program
Rheumatology congress
Clearing limited hkex
European alliance of associations
Investigational new drug
Biologics license application
Chief medical officer
Juno therapeutics
Bristol myers squibb
Stock code
vimarsana © 2020. All Rights Reserved.